Work

Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS-Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.2749.2749

Authors: Kira Gritsman, Robert P. Hasserjian, Taneisha Sinclair, David M. Weinstock, Britta Will, Ulrich Steidl, Karen K. Ballen, Amir T. Fathi, Amit Verma, Dejan Juric, Philip C. Amrein

Institutions: Albert Einstein College of Medicine, Massachusetts General Hospital, Dana-Farber Cancer Institute, Harvard University, Montefiore Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979893875

FWCI:

Cites:

Cited by:

Related to: 10